- By Indication
Inflammatory and Autoimmune DiseasesRespiratory DiseasesInfectious DiseasesRare DiseaseGut Microbiota Research ServiceBy Modality
Preclinical Model Strategies for T-Cell Engagers: From Oncology to Autoimmune Disease
2026-10-27
11:00 AM ET
Dr. Wanjun Yuan & Dr. Haiqiao SunOne TCE Modality. Two Disease Contexts. Different Preclinical Questions.
'/%3e%3c/svg%3e)
Oncology
Browse Drug Type
Explore our comprehensive collection of organized by drug modality. Each category contains validated models for specific disease indications.
Antibody-Drug Conjugate
GemPharmatech provides integrated in vitro and in vivo solutions for ADC development, spanning target characterization, efficacy evaluation, pharmacokinetics, tumor distribution, resistance modeling, and combination strategies.
In Vivo CAR-T
In vivo CAR-T represents an emerging approach to adoptive cell therapy in which CAR constructs are delivered directly to target immune cells within the body — bypassing the ex vivo manufacturing steps required by conventional CAR-T.
T-Cell Engager
T-cell engagers (TCEs) represent a compelling class of bispecific molecules designed to redirect cytotoxic T cells to tumor cells, bypassing the need for MHC-mediated antigen presentation.
Tumor Model Resources
GemPharmatech's oncology platform encompasses a comprehensive library of tumor models — including syngeneic, CDX, and PDX models — spanning a broad range of cancer types to support diverse preclinical research needs.
End-to-End Preclinical Solutions
Comprehensive preclinical services supporting model development, efficacy studies, phenotyping, imaging, PK/PD, pathology, and translational evaluation in oncology.
Molecular Biology Analysis
Backed by extensive project experience and a robust detection infrastructure, the platform delivers efficient, reproducible biomarker and pharmacodynamic endpoint testing across a broad range of studies. The platform also supports pharmacokinetic (PK) evaluation, including the assessment of small molecule and large molecule conjugated drugs.
Preclinical Pathology Services
GemPharmatech's histopathology laboratory provides end-to-end tissue analysis services supporting drug discovery, preclinical safety assessment, and translational research.
PK/PD Services
GemPharmatech's preclinical PK/PD Services deliver end-to-end, customized solutions backed by extensive experience across a broad range of drug modalities — including antibodies, fusion proteins, vaccines, cell & gene therapies, and small molecule drugs.
Ready to Accelerate Your Research?
Newsletter Signup
'%3e%3cpath%20d='M13.6882%2012L23.6426%202.06059C23.8678%201.83321%2023.9941%201.52611%2023.9941%201.20607C23.9941%200.886035%2023.8678%200.578937%2023.6426%200.351553C23.4152%200.126341%2023.1081%200%2022.7881%200C22.468%200%2022.1609%200.126341%2021.9335%200.351553L11.9941%2010.306L2.05473%200.351553C1.82735%200.126341%201.52025%200%201.20021%200C0.880175%200%200.573077%200.126341%200.345693%200.351553C0.120482%200.578937%20-0.00585938%200.886035%20-0.00585938%201.20607C-0.00585937%201.52611%200.120482%201.83321%200.345693%202.06059L10.3001%2012L0.345693%2021.9394C0.120482%2022.1668%20-0.00585937%2022.4739%20-0.00585938%2022.7939C-0.00585938%2023.114%200.120482%2023.4211%200.345693%2023.6484C0.573077%2023.8737%200.880175%2024%201.20021%2024C1.52025%2024%201.82735%2023.8737%202.05473%2023.6484L11.9941%2013.694L21.9335%2023.6484C22.1666%2023.8397%2022.4624%2023.9374%2022.7635%2023.9226C23.0646%2023.9079%2023.3494%2023.7816%2023.5626%2023.5684C23.7757%2023.3553%2023.902%2023.0704%2023.9168%2022.7694C23.9316%2022.4683%2023.8338%2022.1724%2023.6426%2021.9394L13.6882%2012Z'%20fill='black'%20fill-opacity='0.96'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_2458_12695'%3e%3crect%20width='24'%20height='24'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
'%3e%3cpath%20d='M13.6882%2012L23.6426%202.06059C23.8678%201.83321%2023.9941%201.52611%2023.9941%201.20607C23.9941%200.886035%2023.8678%200.578937%2023.6426%200.351553C23.4152%200.126341%2023.1081%200%2022.7881%200C22.468%200%2022.1609%200.126341%2021.9335%200.351553L11.9941%2010.306L2.05473%200.351553C1.82735%200.126341%201.52025%200%201.20021%200C0.880175%200%200.573077%200.126341%200.345693%200.351553C0.120482%200.578937%20-0.00585938%200.886035%20-0.00585938%201.20607C-0.00585937%201.52611%200.120482%201.83321%200.345693%202.06059L10.3001%2012L0.345693%2021.9394C0.120482%2022.1668%20-0.00585937%2022.4739%20-0.00585938%2022.7939C-0.00585938%2023.114%200.120482%2023.4211%200.345693%2023.6484C0.573077%2023.8737%200.880175%2024%201.20021%2024C1.52025%2024%201.82735%2023.8737%202.05473%2023.6484L11.9941%2013.694L21.9335%2023.6484C22.1666%2023.8397%2022.4624%2023.9374%2022.7635%2023.9226C23.0646%2023.9079%2023.3494%2023.7816%2023.5626%2023.5684C23.7757%2023.3553%2023.902%2023.0704%2023.9168%2022.7694C23.9316%2022.4683%2023.8338%2022.1724%2023.6426%2021.9394L13.6882%2012Z'%20fill='%23008077'%20fill-opacity='0.96'/%3e%3c/g%3e%3cdefs%3e%3cclipPath%20id='clip0_2458_12695'%3e%3crect%20width='24'%20height='24'%20fill='white'/%3e%3c/clipPath%3e%3c/defs%3e%3c/svg%3e)
We value your privacy
This website will store cookies on your computer. These cookies are used to collect information about how you interact with this website and enable us to remember you. We use this information to improve and customize your browsing experience, as well as to analyze and collect relevant data and metrics about visitors on this website and other platforms. For more information about the cookies we use, please refer to our privacy policy
If you decline, your information will not be tracked when visiting this website. A cookie will be used in your browser to remember your preference settings that you have not accepted.
Contact Us
Schedule a Meeting
Let us know which event you're attending and we'd be happy to connect with you.